MTM1 mutations in X-linked myotubular myopathy
- PMID: 10790201
- DOI: 10.1002/(SICI)1098-1004(200005)15:5<393::AID-HUMU1>3.0.CO;2-R
MTM1 mutations in X-linked myotubular myopathy
Abstract
X-linked myotubular myopathy (XLMTM; MIM# 310400) is a severe congenital muscle disorder caused by mutations in the MTM1 gene. This gene encodes a dual-specificity phosphatase named myotubularin, defining a large gene family highly conserved through evolution (which includes the putative anti-phosphatase Sbf1/hMTMR5). We report 29 mutations in novel cases, including 16 mutations not described before. To date, 198 mutations have been identified in unrelated families, accounting for 133 different disease-associated mutations which are widespread throughout the gene. Most point mutations are truncating, but 26% (35/133) are missense mutations affecting residues conserved in the Drosophila ortholog and in the homologous MTMR1 gene. Three recurrent mutations affect 17% of the patients, and a total of 21 different mutations were found in several independent families. The frequency of female carriers appears higher than expected (only 17% are de novo mutations). While most truncating mutations cause the severe and early lethal phenotype, some missense mutations are associated with milder forms and prolonged survival (up to 54 years).
Copyright 2000 Wiley-Liss, Inc.
Similar articles
-
Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy.Hum Mutat. 1999;14(4):320-5. doi: 10.1002/(SICI)1098-1004(199910)14:4<320::AID-HUMU7>3.0.CO;2-O. Hum Mutat. 1999. PMID: 10502779
-
Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype.Hum Genet. 2003 Feb;112(2):135-42. doi: 10.1007/s00439-002-0869-1. Epub 2002 Nov 28. Hum Genet. 2003. PMID: 12522554
-
Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism.Neuromuscul Disord. 2005 Mar;15(3):245-52. doi: 10.1016/j.nmd.2004.12.005. Epub 2005 Jan 28. Neuromuscul Disord. 2005. PMID: 15725586
-
[Myotubular myopathy].Rev Neurol (Paris). 2000 Nov;156(11):960-4. Rev Neurol (Paris). 2000. PMID: 11119047 Review. French.
-
The myotubularin family: novel phosphoinositide regulators.IUBMB Life. 2002 Jan;53(1):37-43. doi: 10.1080/15216540210812. IUBMB Life. 2002. PMID: 12018406 Review.
Cited by
-
Defective autophagy and mTORC1 signaling in myotubularin null mice.Mol Cell Biol. 2013 Jan;33(1):98-110. doi: 10.1128/MCB.01075-12. Epub 2012 Oct 29. Mol Cell Biol. 2013. PMID: 23109424 Free PMC article.
-
Novel Splicing Mutation in MTM1 Leading to Two Abnormal Transcripts Causes Severe Myotubular Myopathy.Int J Mol Sci. 2022 Sep 7;23(18):10274. doi: 10.3390/ijms231810274. Int J Mol Sci. 2022. PMID: 36142184 Free PMC article.
-
Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy.Neuromuscul Disord. 2007 Jul;17(7):562-8. doi: 10.1016/j.nmd.2007.03.010. Epub 2007 May 29. Neuromuscul Disord. 2007. PMID: 17537630 Free PMC article.
-
T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase.Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18763-8. doi: 10.1073/pnas.0900705106. Epub 2009 Oct 21. Proc Natl Acad Sci U S A. 2009. PMID: 19846786 Free PMC article.
-
Dynamin-2 reduction rescues the skeletal myopathy of a SPEG-deficient mouse model.JCI Insight. 2022 Aug 8;7(15):e157336. doi: 10.1172/jci.insight.157336. JCI Insight. 2022. PMID: 35763354 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
